HC Wainwright & Co. Reiterates Buy on Precigen, Maintains $14 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 87.9%

Neg 0% Neu 87.9% Pos 0%

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Precigen (NASDAQ:PGEN) with a Buy and maintains $14 price target.